As on Wednesday, Nautilus Biotechnology Inc (NASDAQ: NAUT) got off with the flyer as it spiked 18.72% to $2.22, before settling in for the price of $1.87 at the close. Taking a more long-term approach, NAUT posted a 52-week range of $0.62-$2.54.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -4.55%. Meanwhile, its Annual Earning per share during the time was -4.55%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 6.25%. This publicly-traded company’s shares outstanding now amounts to $126.31 million, simultaneously with a float of $60.06 million. The organization now has a market capitalization sitting at $280.40 million. At the time of writing, stock’s 50-day Moving Average stood at $1.8900, while the 200-day Moving Average is $1.0600.
Nautilus Biotechnology Inc (NAUT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Nautilus Biotechnology Inc’s current insider ownership accounts for 52.45%, in contrast to 25.80% institutional ownership. According to the most recent insider trade that took place on Nov 06 ’25, this organization’s Chief Marketing Officer bought 4,000 shares at the rate of 1.49, making the entire transaction reach 5,960 in total value, affecting insider ownership by 4,000. Preceding that transaction, on Sep 05 ’25, Company’s CEO, President, and Secretary bought 116,500 for 0.67, making the whole transaction’s value amount to 78,544. This particular insider is now the holder of 10,258,221 in total.
Nautilus Biotechnology Inc (NAUT) Earnings and Revenue Records
Nautilus Biotechnology Inc’s EPS increase for this current 12-month fiscal period is 6.25% and is forecasted to reach -0.61 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 5.67% through the next 5 years, which can be compared against the -4.55% growth it accomplished over the previous five years trading on the market.
Nautilus Biotechnology Inc (NASDAQ: NAUT) Trading Performance Indicators
Let’s observe the current performance indicators for Nautilus Biotechnology Inc (NAUT). It’s Quick Ratio in the last reported quarter now stands at 14.95.
In the same vein, NAUT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.50, a figure that is expected to reach -0.14 in the next quarter, and analysts are predicting that it will be -0.61 at the market close of one year from today.
Technical Analysis of Nautilus Biotechnology Inc (NAUT)
Through scrutinizing the latest numbers posted by the [Nautilus Biotechnology Inc, NAUT], it can be observed that its last 5-days Average volume of 0.2 million was lower the volume of 0.22 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 42.01% While, its Average True Range was 70.88.
Raw Stochastic average of Nautilus Biotechnology Inc (NAUT) in the period of the previous 100 days is set at 83.33%, which indicates a major fall in contrast to 100.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1200 that was lower than 0.1300 volatility it exhibited in the past 100-days period.
